[Therapy results with nalidixic acid in chronic urinary tract infection].
D000368:Aged; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects / Q000302:isolation & purification; D002908:Chronic Disease; D004352:Drug Resistance, Microbial; D004927:Escherichia coli Infections / Q000188:drug therapy; D006801:Humans; D008875:Middle Aged; D009268:Nalidixic Acid / Q000627:therapeutic use*; D011512:Proteus Infections / Q000188:drug therapy; D011552:Pseudomonas Infections / Q000188:drug therapy; D011704:Pyelonephritis / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy; D013449:Sulfonamides / Q000494:pharmacology; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000382:microbiology
D000900:Anti-Bacterial Agents; D013449:Sulfonamides; D009268:Nalidixic Acid
Therapieergebnisse mit Nalidixinsäure beim chronischen Harnweginfekt.